[1]中华医学会传染病与寄生虫病学分会和肝脏学分会.病毒性肝炎防治指南[J].中华肝脏病杂志, 2000, 8 (6) :324-329.
|
[2] 传染病与寄生虫病学会人工肝学组.人工肝支持系统的适应证、禁忌证和疗效判断[J].中华肝脏病杂志, 2002, 10 (6) :405.
|
[3]O’GRADY JG.Acute liver failure[J].Postgrad Med J, 2005, 81 (953) :148-154.
|
[4]林世德, 罗亚文, 苏毅, 等.重型肝炎研究进展[J].实用肝脏病杂志, 2009, 12 (1) :73-75.
|
[5]Shito M, Balis UJ, Tompkins RG, et al.A fulminant hepaticfailure model in the rat:involvement of interleukin-1betaand tumor necrosis factor-alpha[J].DigDis Sci, 2001, 46 (8) :1700-1708.
|
[6]罗明, 曹武德.微生态调节剂治疗重型肝炎内毒素血症的研究进展[J].临床肝胆病杂志, 2011, 27 (7) :775-778.
|
[7]Nishimura A, Umehara Y, Umehara M, et al.Plasma ex-change-based plasma recycling dialysis system as a poten-tial platform for artificial liver support[J].Artif Organs, 2006, 30 (8) :629-633.
|
[8]Li LJ, Zhang YM, Liu XL, et al.Artificial liver support systemin China:a review over the last 30 years[J].Ther Apher Di-al, 2006, 10 (2) :160-167.
|
[9]吴锦瑜, 杜美英, 曹旺发.人工肝血浆置换术治疗早期重型肝炎疗效观察[J].临床肝胆病杂志, 2007, 23 (1) :53-54.
|
[10]徐少保, 高人焘, 沈强.血浆置换治疗重型肝炎的疗效评价[J].实用肝脏病杂志, 2008, 11 (5) , 305-306.
|
[11]Agishi T, Nakagawa Y, Terakoka S, et al.Plasm a exchangeas a rescue strategy for hepatic failure[J].ASAIO J, 1994, 40 (1) :77.
|
[12]Li N, Gao YF, Su F, et al.The value of MELD in the assess-ment of short-term prognosis of severe hepatitis by artificialliver treatment[J].Chin J Hepatol, 2011, 19 (6) :469-470.
|